It is necessary to further clarify the pathogenic relationship between GLUR5 and human refractory temporal lobe epilepsy and its pathological mechanism in refractory temporal lobe epilepsy, to provide a possible theoretical basis for the development of new antiepileptic drugs (52). This evidence concerns the gene GRIK1 and temporal lobe epilepsy.